Episode Details
Back to Episodes
Episode 499: APCCC 2026 - Radioligands in Prostate Cancer
Published 5 months ago
Description
This session features expert Michael Morris discussing radioligand therapy, adaptive dosing, retreatment strategies, and the latest insights in prostate cancer treatment. Gain a deep understanding of current practices, challenges, and future directions in radiopharmaceuticals.